Skip to content

Culturally-Tailored HIV Risk Reduction for African-American MSM

Culturally-Tailored HIV Risk Reduction for African-American MSM (Project ABLE: African-Americans Building Life Empowerment

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00691561
Acronym
Project ABLE
Enrollment
220
Registered
2008-06-05
Start date
2008-06-30
Completion date
2010-03-31
Last updated
2010-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV Infections

Keywords

HIV Prevention, African American, Black, gay, Men who have sex men, HIV Seronegativity

Brief summary

The purpose of this study to conduct a small randomized control trial to compare the relative effectiveness of a single-session of HIV testing and counseling risk reduction intervention (HCT-only) to an enhanced intervention that includes the standard HCT intervention plus a theory-based and culturally-tailored group-level intervention designed to reduce or eliminate HIV and STI risk behaviors (HCT-plus) among African-American men who have sex with men (AA-MSM).

Detailed description

The HCT-plus intervention will consist of the HCT-only intervention, as well as 8 small group intervention sessions focused on HIV risk reduction. Small groups will consist of 10 men who will meet once-a-week for 8 consecutive weeks. Each meeting will last approximately 2 hours. In each small group session, staff will work with men to reassess their HIV risk behavior, re-prioritize their goals as appropriate, and provide motivational support for their risk reduction accomplishments. Participants will be asked to discuss ways they have successfully avoided HIV risk behavior since the previous session, as well as to discuss situations in which they found it difficult to avoid risk. Staff will reinforce successful risk avoidance, and problem-solve with men to overcome barriers to risk reduction.

Interventions

BEHAVIORALProject ABLE

Participants will receive HIV counseling and testing. Those selected for the intervention arm will attend small groups consisting of 10 men who meet once a week for 8 consecutive weeks. The weekly two hour discussion sessions will address HIV risk behavior within a framework of contextual influences that may moderate men's risk reduction motivation and behavior. The factors include identity, stigma, connections to community, and situation factors.

Sponsors

Centers for Disease Control and Prevention
CollaboratorFED
Diverse and Resilient
CollaboratorUNKNOWN
Charles D Productions
CollaboratorUNKNOWN
Milwaukee LGBT Community Center
CollaboratorOTHER
Medical College of Wisconsin
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* reside in Milwaukee county; * are at least 18 years of age; * self-identify as male; * self-identify as Black or African-American; * can provide informed consent; * report unprotected anal sex with a man in the past 3 months; * report at least two sexual partners with whom they have had unprotected anal or vaginal sex in the past 3 months; * are willing to be tested for HIV using rapid oral fluid procedures or willing to provide evidence of HIV seropositivity

Exclusion criteria

* Under 18 years of age, * involvement in a HIV prevention study currently or in the past 6 months, * Participation in the pilot phase

Design outcomes

Primary

MeasureTime frame
The HCT-plus intervention will result in a greater proportion of men who abstain from anal and vaginal intercourse.3 months after completing intervention

Secondary

MeasureTime frame
The HCT-plus intervention will result in a smaller proportion of men who had an act of anal or vaginal intercourse without the use of a condom.3 months after completing the intervention

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026